-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

628. Aggressive Lymphomas: Cellular Therapies: Poster II

Symposia: Aggressive Lymphomas: Cellular Therapies Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Lymphomas, Non-Hodgkin lymphoma, Assays, Elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Immunotherapy, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Registries, Technology and Procedures, Study Population, Radiation Therapy, Human, Measurable Residual Disease
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Michele Clerico, MD1*, Axel André, MD2*, Pierre Sesques, MD3*, Jean Galtier, MD4*, Gwenaelle Viard5*, Sylvain Choquet, MD6*, Gabriel Brisou, MD, PhD7*, Emilie Corvilain, MD8*, Laure Ricard, MD9*, Justine Decroocq, MD10*, Adrien Chauchet, MD11*, Amandine Durand, MD12*, Sylvain Carras, MD, PhD13*, Fabrice Jardin, MD, PhD14*, Magalie Joris, MD15*, Marie-Thérèse Rubio, MD, PhD16*, Catherine Thieblemont, MD17, Alexandra Marquet18*, Cyrielle de Lacheisserie19*, Vivien Dupont20*, David Boutboul, MD, PhD21*, Thierry Lamy, MD22* and Roberta Di Blasi, MD, PhD23*

1Assistance Publique Hôpitaux de Paris - Hôpital Saint-Louis, University of Paris, Paris, France
2Service d'Hématologie Lymphoïde, Hôpital Universitaire Henri-Mondor, Créteil, France
3CHU Lyon-Sud, Lyon, France
4CHU Bordeaux, Service D'Hématologie Clinique et Thérapie Cellulaire, Pessac, France
5CHU de Rennes, Hôpital Pontchaillou, Rennes, France
6Pitie-Salpetriere Hospital, Paris, France
7Institut Paoli-Calmettes, Marseille, France
8Hôpital Saint-Louis, APHP, Paris, France
9Department of hematology, Saint Antoine Hospital, APHP, Paris, France
10Clinical Hematology Department, Hopital Cochin, APHP, Paris, France, Paris, France
11CHU de Besançon, Hôpital Jean Minjoz, Besançon, France
12Department of Hematology, University Hospital F. Mitterrand, Dijon, France
13University Grenoble Alpes, Institute for Advanced Biosciences, University Hospital, La Tronche, France
14Department of Hematology, Centre Henri Becquerel, Rouen, France
15Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
16Department of Hematology, Nancy University Hospital, Vandoeuvre Les Nancy, France
17Hospital Saint-Louis, Paris, France
18Lysarc, Lyon Sud Hospital, Biostatistics Unit, Pierre-Bénite, Lyon, France
19LYSARC, Pierre Bénite, France
20LYSARC, Pierre BéNite, FRA
21Service d'Hématologie Clinique, Hôpital Cochin, Paris, Paris, France
22Hospital Pontchaillou, Rennes, AL, France
23Department of Hematology, Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, University of Paris, Paris, France

Jeremy S. Abramson, MD1, Maria Lia Palomba, MD2, Leo I. Gordon, MD3, Matthew Lunning, DO4, Michael Wang, MD5, Jon E. Arnason, MD6, Manali Kamdar, MD, MBBS7*, David G. Maloney, MD, PhD8, Mazyar Shadman, MD, MPH8*, Charalambos Andreadis, MD, MS9*, Alison R. Sehgal, MD10, Scott R. Solomon, MD11, Nilanjan Ghosh, MD, PhD12, Juliana E. Hidalgo-López, MD13*, Jing Wang, MS, MA14*, Ken Ogasawara, PhD, MPH13*, Ashvin Singh, MBS13* and Tanya Siddiqi, MD, MBBS15*

1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
2Memorial Sloan Kettering Cancer Center, New York, NY
3Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
4University of Nebraska Medical Center, Omaha, NE
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Beth Israel Deaconess Medical Center, Boston, MA
7University of Colorado Cancer Center, Aurora, CO
8Fred Hutch Cancer Center, University of Washington, Seattle, WA
9University of California, San Francisco, San Francisco, CA
10University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
11Northside Hospital Cancer Institute, Atlanta, GA
12Atrium Health, Levine Cancer Institute, Charlotte, NC
13Bristol Myers Squibb, Princeton, NJ
14Bristol Myers Squibb, Seattle, WA
15City of Hope National Medical Center, Duarte, CA

Christopher R D'Angelo, MD1, Charles Enke, MD2*, Julie M. Vose, MD, MBA3, Robert Gregory Bociek, MD, MSc2, Fang Yu, PhD4*, Makayla Schissel, MPH4* and Matthew Lunning, DO2

1Fred and Pamela Buffett Cancer Center/Division of Hematology and Oncology/Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
2University of Nebraska Medical Center, Omaha, NE
3Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE
4Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE

Marissa Morales Del Real, PhD1*, John H. Baird, MD2, Lu Chen, PhD3*, Joo Y. Song, MD2, Xiuli Wang, PhD4, Swetha Kambhampati Thiruvengadam, MD2, Alan Macias1*, Emanuela C Marcucci1*, Soungchul Cha, PhD4*, Zhenyuan Dong, PhD5*, Teresa Kim5*, Baishakhi Barva, MBBS5*, Sandrine Puverel, PhD2*, Qing Liu-Michael, PhD5*, Hazel Ting-Ying Cheng, PhD6*, Stephen J. Forman, MD, FACP7, Larry W. Kwak, MD, PhD2 and Lihua E. Budde, MD, PhD2

1T-Cell Therapeutics Research Laboratories, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
4Beckman Research Institute, City of Hope, Duarte, CA
5City of Hope National Medical Center, Duarte, CA
6PeproMene Bio. Inc, Irvine, CA
7Hematology and HCT, City of Hope National Medical Center, Duarte, CA

Brandon S. Imber, MD, MA1, Anna Brosoff2*, Emma Roszak2*, Devin McAvoy3*, Kinga K. Hosszu, PhD4*, Alexander P. Boardman, MD5*, Parastoo B Dahi, MD6*, Gunjan L. Shah, MD6, Michael Scordo, MD7, Jae H. Park, MD5, Miguel-Angel Perales, MD8, Gilles Salles, MD, PhD9, Maria Lia Palomba, MD5 and Joachim Yahalom, MD1

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York
3Department of Pediatrics, Immune Discovery and Modeling Service, Sloan Kettering Institute, New York, NY
4Department of Pediatrics, Immune Discovery and Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY
5Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
9Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Blandine Guffroy1*, Emmanuel Bachy, MD, PhD2, Roberta Di Blasi, MD, PhD3*, Hanane Guedon, MD4*, Fabien Le Bras, MD5*, Ibrahim Yakoub-Agha, MD, PhD6*, Stephanie Guidez, MD7*, Laure Ricard, MD8*, Thomas Gastinne, MD9*, Cristina Castilla-Llorente, MD10*, Justine Decroocq, MD11*, Gabriel Brisou, MD, PhD12*, Sylvain Choquet, MD13*, Olivier Casasnovas, MD14*, Michael Loschi, MD, PhD15*, Jacques-Olivier Bay, MD, PhD16*, Fabrice Jardin, MD, PhD17*, Anne Cuozzo18*, Elodie Gat19*, Alexandra Marquet20*, Steven Le Gouill, MD, PhD21, Roch Houot, MD, PhD22* and Pierre Bories23*

1Institut de Cancerologie Strasbourg Europe, Strasbourg, France
2Lyon Sud Hospital, Lyon, France
3Hôpital Saint Louis, Paris, France
4CHU de Montpellier, Montpellier, France
5Henri Mondor Hospital, Creteil, France
6Hematology Department, Lille University Hospital, Lille, France
7University Hospital of Poitiers, Poitiers, France
8Saint Antoine Hospital, Paris, France
9CHU Hôtel Dieu, Nantes, France
10Gustave Roussy Cancer Campus, Villejuif, France
11Hopital Cochin, Paris, France
12Institut Paoli-Calmettes, Marseille, France
13Pitie-Salpetriere Hospital, Paris, France
14François Mitterand Hospital, Dijon, FRA
15Hematology Department, Nice University Hospital, Nice, France
16CHU Clermont-Ferrrand, Clermont Ferrand, France
17Centre Henri Becquerel, Rouen, France
18Department of biostatistics, Lymphoma Academic Research Organisation (LYSARC), Pierre Benite, France
19Department of biostatistics, Lymphoma Academic Research Organisation (LYSARC), Pierre Bénite, France
20Lysarc, Lyon Sud Hospital, Biostatistics Unit, Pierre-Bénite, Lyon, France
21Institut Curie, Saint-Cloud, France
22Rennes university hospital - Hospital Pontchaillou, Rennes, France
23Toulouse University Institute of Cancer, Toulouse, France

Jeremy S. Abramson, MD1, Manali Kamdar, MD, MBBS2*, Fei Fei Liu, GDCE, MBA3*, Alessandro Crotta, MD4*, Alessandro Previtali, MSc4*, Sven L. Klijn, MSc3*, Pearl Wang, MSc5*, Yixie Zhang, PhD5*, Ashley Bonner, PhD5* and Matthew Lunning, DO6

1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
2University of Colorado Cancer Center, Aurora, CO
3Bristol Myers Squibb, Princeton, NJ
4Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
5Eversana, Burlington, ON, Canada
6University of Nebraska Medical Center, Omaha, NE

Anna Dodero, MD1*, Giusy Ceparano, MD1,2*, Beatrice Casadei, MD3*, Piera Angelillo, MD4*, Stefania Bramanti5*, Maria Chiara Tisi6*, Silva Ljevar7*, Annalisa Chiappella8, Barbara Botto9*, Ilaria Cutini10*, Patrizia Chiusolo, MD, PhD11,12*, Anna Maria Barbui, MD13*, Mirko Farina, MD14*, Alice Di Rocco, MD15*, Giovanni Grillo16*, Jacopo Olivieri, MD17*, Mauro Krampera18, Lucia Brunello, PhD19*, Anna Guidetti, MD20*, Pier Luigi Zinzani, MD, PhD3,21, Cristiana Carniti, PhD20* and Paolo Corradini, MD20,22

1Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
2Department of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori; Università degli Studi di Milano, Milano, Italy
3IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli”, Bologna, Italy
4Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
5Bone Marrow Transplantation and Cell Therapy Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy
6Hematology Unit, San Bortolo Hospital, A.U.L.S.S. 8 "Berica", Vicenza, Italy
7Unit of Biostatistics for Clinical Research Department of Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
8Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
9Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy
10Department of Cellular Therapies and Transfusion Medicine, Careggi University Hospital, Firenze, Italy
11Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
12Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
13Department of Oncology and Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
14Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, University of Brescia, ASST Spedali Civili, Brescia, Italy
15Hematology Section, Department of Traslational and Precision Medicine, Sapienza University of Rome, Roma, Italy
16Department of Hematology and Stem Cell Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
17Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
18UOC di Ematologia e Centro Trapianto di Midollo Osseo, Azienda Ospedaliera Universitaria Integrata Verona Policlinico G.B. Rossi, Verona, Italy
19Hematology, AZienda Ospedaliera Santi Antonio e Biagio e CEsare Arrigo, Alessandria, Italy
20Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
21University of Bologna, Bologna, Italy
22University of Milan, Milano, Italy

Jia Wei1,2, Xiaoxi Zhou3*, Hui Luo1*, Yang Cao1*, Jiaqi Guo2*, Jie Zhao2*, Lifang Huang1,2*, Ang Zhang4*, Lihong Liu5*, Weiwei Tian2* and Yicheng Zhang1*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Hematology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China
3Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4Department of Comprehensive Basic Experiment (Division Two), The Ninth Medical Center of Chinese PLA General Hospital, Beijing, China
5Department of Hematology, The Fourth Hospital of Hebei Medical University, Hebei Tumor Hospital, Shijiazhuang, China

Jason R. Westin, MD1, Alex F. Herrera, MD2, Ryan Lynch, MD3*, Jeremy S. Abramson, MD4, Don A. Stevens, MD5, Matthew Matasar, MD, MS6, Lindsey Fitzgerald, MD7, Alan P Skarbnik, MD8, Chaitanya Iragavarapu, MD9*, James H Essell, MD10, Bradley D. Hunter, MD, MPH11, Akil Merchant, MD12, Indumathy Varadarajan, MD13, Anand Tandra, MD14*, Edward Licitra, MD, PhD15*, Locke Johnson Bryan, MD16, Rushang D. Patel, MD, PhD17*, Rajesh Behl, MD18*, Jeff P. Sharman, MD19, Houston Holmes, MD, MBA20*, Habte A. Yimer, MD21, Mitul Gandhi, MD22, Nosha Farhadfar, MD23*, Nancy L. Bartlett, MD24, Michael Leukam, MD25*, Tahir Latif, MBBS, MBA26*, Paolo Caimi, MD27, Jean Yared, MD28*, Amy Feng, PhD29*, Lynn Navale, MS29*, Sri Ghatta, PhD29*, John B. Le Gall, MD, MBA29*, Zachary J Roberts, MD, PhD29* and John M. Burke30

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Fred Hutchinson Cancer Center, Seattle, WA
4Massachusetts General Hospital, Boston, MA
5Norton Cancer Institute, Louisville, KY
6Rutgers Cancer Institute, New Brunswick, NJ
7Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
8Novant Health, Charlotte, NC
9Department of Hematology, University of Kentucky, Lexington, KY
10Oncology Hematology Care, Cincinnati, OH
11Intermountain Healthcare, Salt Lake City, UT
12Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA
13University of Virginia Health, Charlottesville, VA
14Indiana Blood and Marrow Transplantation, Indianapolis, IN
15Astera Cancer Care, East Brunswick, NJ
16Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA
17AdventHealth Cancer Institute, Orlando, FL
18Sutter Health, Berkeley, CA
19Willamette Valley Cancer Institute, Sarah Cannon Research, Eugene, OR
20Texas Oncology/Baylor Sammons Cancer Center, Dallas, TX
21Texas Oncology-Tyler, US Oncology Research, Tyler, TX
22Virginia Cancer Specialists, US Oncology Research, Gainesville, VA
23Sarah Cannon Transplant & Cellular Therapy Program at Methodist Hospital, San Antonio, TX
24Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
25Beth Israel Deaconess Medical Center, Boston, MA
26University of Cincinnati Cancer Center, Cincinnati, OH
27Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
28University of Maryland Medical Center, Baltimore, MD
29Allogene Therapeutics, San Francisco, CA
30US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO

*signifies non-member of ASH